The stock of Jaguar Health Inc (JAGX) has gone up by 7.50% for the week, with a 25.94% rise in the past month and a -16.70% drop in the past quarter. The volatility ratio for the week is 20.98%, and the volatility levels for the past 30 days are 16.63% for JAGX. The simple moving average for the past 20 days is 12.86% for JAGX’s stock, with a -67.43% simple moving average for the past 200 days.
Is It Worth Investing in Jaguar Health Inc (NASDAQ: JAGX) Right Now?
Additionally, the 36-month beta value for JAGX is 1.34. There are mixed opinions on the stock, with 1 analysts rating it as a “buy,” 0 rating it as “overweight,” 0 rating it as “hold,” and 0 rating it as “sell.”
The public float for JAGX is 196.63M and currently, short sellers hold a 10.02% ratio of that float. The average trading volume of JAGX on April 15, 2024 was 45.50M shares.
JAGX) stock’s latest price update
Jaguar Health Inc (NASDAQ: JAGX)’s stock price has decreased by -16.00 compared to its previous closing price of 0.11. However, the company has seen a 7.50% increase in its stock price over the last five trading sessions. InvestorPlace reported 2024-04-10 that Former meme stock Jaguar Health (NASDAQ: JAGX ) has won the approval of certain measures meant to help maintain its Nasdaq listing. These include an extension to Aug. 13 to regain compliance by getting its price over $1 as well as JAGX stockholder approval of a potential reverse stock split.
Analysts’ Opinion of JAGX
Many brokerage firms have already submitted their reports for JAGX stocks, with Cantor Fitzgerald repeating the rating for JAGX by listing it as a “Overweight.” The predicted price for JAGX in the upcoming period, according to Cantor Fitzgerald is $5 based on the research report published on July 07, 2021 of the previous year 2021.
Rodman & Renshaw, on the other hand, stated in their research note that they expect to see JAGX reach a price target of $2. The rating they have provided for JAGX stocks is “Buy” according to the report published on July 11th, 2017.
JAGX Trading at 10.99% from the 50-Day Moving Average
After a stumble in the market that brought JAGX to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -92.60% of loss for the given period.
Volatility was left at 16.63%, however, over the last 30 days, the volatility rate increased by 20.98%, as shares surge +20.24% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -12.75% lower at present.
During the last 5 trading sessions, JAGX rose by +7.50%, which changed the moving average for the period of 200-days by -81.57% in comparison to the 20-day moving average, which settled at $0.0808. In addition, Jaguar Health Inc saw -40.36% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for JAGX
Current profitability levels for the company are sitting at:
- -3.48 for the present operating margin
- 0.73 for the gross margin
The net margin for Jaguar Health Inc stands at -4.23. The total capital return value is set at -0.92. Equity return is now at value -1919.14, with -84.10 for asset returns.
Based on Jaguar Health Inc (JAGX), the company’s capital structure generated 0.88 points at debt to capital in total, while cash flow to debt ratio is standing at -0.92. The debt to equity ratio resting at 7.3. The interest coverage ratio of the stock is -5.31.
Currently, EBITDA for the company is -31.53 million with net debt to EBITDA at -0.97. When we switch over and look at the enterprise to sales, we see a ratio of 5.05. The receivables turnover for the company is 4.47for trailing twelve months and the total asset turnover is 0.19. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.00.
Conclusion
In conclusion, Jaguar Health Inc (JAGX) has seen mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others rating it as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
